Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Beclomethasone on Lens Opacification in Asthma
NCT00254956Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Primary completion
- Jun 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (2 arms), sponsored by Sanofi. Primary endpoint: Occurrence of a Class I lens event for nuclear, cortical, or posterior subcapsular lens opacification at 12 months. Started Jan 2004; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00254956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254956.